Eris Lifesciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	3,518	3,921	3,822	4,061	3,551
Depreciation & Amortization	3,124	1,797	1,144	626.21	423.02
Other Amortization	30.6	28.2	26.58	20.84	6.83
Loss (Gain) From Sale of Assets	9.2	21.4	20.18	42.54	0.06
Loss (Gain) From Sale of Investments	-30	-93.8	-69.33	-167.61	-49.77
Stock-Based Compensation	91.3	7.5	31.21	13.55	11.2
Provision & Write-off of Bad Debts	-	-	0.67	0.02	65.1
Other Operating Activities	2,647	166.8	-302.45	-515.03	-307.45
Change in Accounts Receivable	-91.1	-570.9	-1,171	-204.8	158.96
Change in Inventory	-943.6	-169.4	47.44	-234.45	-249.91
Change in Accounts Payable	679.4	909.8	-104.97	151.59	25.66
Change in Other Net Operating Assets	1,615	-1,157	-526.45	-11.35	118.56
Operating Cash Flow	10,650	4,860	2,917	3,783	3,754
Operating Cash Flow Growth	119.13%	66.59%	-22.88%	0.77%	38.42%
Capital Expenditures	-1,550	-1,292	-8,414	-1,210	-257.63
Sale of Property, Plant & Equipment	3.7	-	1.37	7.58	0.38
Cash Acquisitions	-11,690	-5,668	-6,555	-	-
Investment in Securities	-484.3	484.1	4,904	-1,881	-2,946
Other Investing Activities	12,923	-12,053	35.61	49.32	-0.4
Investing Cash Flow	-799.7	-18,545	-9,821	-3,196	-3,234
Long-Term Debt Issued	14,364	16,231	11,678	450.01	0.1
Long-Term Debt Repaid	-18,424	-1,603	-3,587	-115.01	-59.45
Total Debt Repaid	-18,424	-1,603	-3,587	-115.01	-59.45
Net Debt Issued (Repaid)	-4,059	14,628	8,091	335	-59.35
Issuance of Common Stock	72.2	45.4	22.78	71.96	-
Common Dividends Paid	-1,001	-	-999.11	-816.23	-746.79
Other Financing Activities	-3,826	-875.7	-234.3	-37.72	-17.81
Financing Cash Flow	-8,813	13,798	6,880	-446.99	-823.95
Miscellaneous Cash Flow Adjustments	17.7	269.6	74.9	-	-
Net Cash Flow	1,055	382.3	51.52	139.55	-303.92
Free Cash Flow	9,100	3,569	-5,497	2,572	3,496
Free Cash Flow Growth	155.01%	-	-	-26.42%	191.61%
Free Cash Flow Margin	31.61%	17.92%	-33.08%	19.40%	29.31%
Free Cash Flow Per Share	66.77	26.21	-40.37	18.93	25.73
Cash Interest Paid	1,451	773	234.3	38.5	17.81
Cash Income Tax Paid	978.8	1,008	772.08	832.85	685.35
Levered Free Cash Flow	6,527	2,357	-6,892	1,623	2,560
Unlevered Free Cash Flow	7,973	2,887	-6,729	1,649	2,571
Change in Working Capital	1,260	-987.4	-1,755	-299.01	53.27

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.